|
1
|
Couto GK, Fernandes RO, Lacerda D,
Campos-Carraro C, Turck P, Bianchi SE, Ferreira GD, Brum IS,
Bassani VL, Bello-Klein A and Araujo ASR: Profile of
pterostilbene-induced redox homeostasis modulation in cardiac
myoblasts and heart tissue. J Biosci. 43:931–940. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakayama KI and Nakayama K: Ubiquitin
ligases: Cell-cycle control and cancer. Nat Rev Cancer. 6:369–381.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee EK and Diehl JA: SCFs in the new
millennium. Oncogene. 33:2011–2018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Skaar JR, Pagan JK and Pagano M:
Mechanisms and function of substrate recruitment by F-box proteins.
Nat Rev Mol Cell Biol. 14:369–381. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: A tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deshaies RJ and Joazeiro CA: RING domain
E3 ubiquitin ligases. Ann Rev Biochem. 78:399–434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spruck CH, Strohmaier H, Sangfelt O,
Müller HM, Hubalek M, Müller-Holzner E, Marth C, Widschwendter M
and Reed SI: hCDC4 gene mutations in endometrial cancer. Cancer
Res. 62:4535–4539. 2002.PubMed/NCBI
|
|
8
|
Hao B, Oehlmann S, Sowa ME, Harper JW and
Pavletich NP: Structure of a Fbw7-Skp1-cyclin E complex:
Multisite-phosphorylated substrate recognition by SCF ubiquitin
ligases. Mol Cell. 26:131–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Welcker M, Larimore EA, Swanger J,
Bengoechea-Alonso MT, Grim JE, Ericsson J, Zheng N and Clurman BE:
Fbw7 dimerization determines the specificity and robustness of
substrate degradation. Genes Dev. 27:2531–2536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ekholm-Reed S, Goldberg MS, Schlossmacher
MG and Reed SI: Parkin-dependent degradation of the F-box protein
Fbw7β promotes neuronal survival in response to oxidative stress by
stabilizing Mcl-1. Mol Cell Biol. 33:3627–3643. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grim JE, Gustafson MP, Hirata RK, Hagar
AC, Swanger J, Welcker M, Hwang HC, Ericsson J, Russell DW and
Clurman BE: Isoform- and cell cycle-dependent substrate degradation
by the Fbw7 ubiquitin ligase. J Cell Biol. 181:913–920. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tetzlaff MT, Yu W, Li M, Zhang P, Finegold
M, Mahon K, Harper JW, Schwartz RJ and Elledge SJ: Defective
cardiovascular development and elevated cyclin E and notch proteins
in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci USA.
101:3338–3345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Bathina M, Lynch J, Koss B,
Calabrese C, Frase S, Schuetz JD, Rehg JE and Opferman JT: Deletion
of MCL-1 causes lethal cardiac failure and mitochondrial
dysfunction. Genes Dev. 27:1351–1364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang YC and Yeh CH: Inhibition of miR-302
suppresses hypoxia-reoxygenation-induced H9c2 cardiomyocyte death
by regulating Mcl-1 expression. Oxid Med Cell Longev.
2017:79689052017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Inuzuka H, Shaik S, Onoyama I, Gao D,
Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al:
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for
ubiquitylation and destruction. Nature. 471:104–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wertz IE, Kusam S, Lam C, Okamoto T,
Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, et al:
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1
and FBW7. Nature. 471:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thomas RL, Roberts DJ, Kubli DA, Lee Y,
Quinsay MN, Owens JB, Fischer KM, Sussman MA, Miyamoto S and
Gustafsson ÅB: Loss of MCL-1 leads to impaired autophagy and rapid
development of heart failure. Genes Dev. 27:1365–1377. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koepp DM, Schaefer LK, Ye X, Keyomarsi K,
Chu C, Harper JW and Elledge SJ: Phosphorylation-dependent
ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.
Science. 294:173–177. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jackson PK: Ubiquitinating a
phosphorylated Cdk inhibitor on the blades of the Cdc4
beta-propeller. Cell. 112:142–144. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Welcker M, Orian A, Jin J, Grim JE, Harper
JW, Eisenman RN and Clurman BE: The Fbw7 tumor suppressor regulates
glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein
degradation. Proc Natl Acad Sci USA. 101:9085–9090. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding Q, He X, Hsu JM, Xia W, Chen CT, Li
LY, Lee DF, Liu JC, Zhong Q, Wang X and Hung MC: Degradation of
Mcl-1 by β-TrCP Mediates glycogen synthase kinase 3-induced tumor
suppression and chemosensitization. Mol Cell Biol. 27:4006–4017.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maurer U, Charvet C, Wagman AS, Dejardin E
and Green DR: Glycogen synthase kinase-3 regulates mitochondrial
outer membrane permeabilization and apoptosis by destabilization of
MCL-1. Mol Cell. 21:749–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ren H, Koo J, Guan B, Yue P, Deng X, Chen
M, Khuri FR and Sun SY: The E3 ubiquitin ligases β-TrCP and FBXW7
cooperatively mediates GSK3- dependent Mcl-1 degradation induced by
the Akt inhibitor API-1, resulting in apoptosis. Mol Cancer.
12:1462013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Koo J, Yue P, Deng X, Khuri FR and Sun SY:
mTOR Complex 2 stabilizes Mcl-1 protein by suppressing its glycogen
synthase kinase 3-dependent and SCF-FBXW7-mediated degradation. Mol
Cell Biol. 35:2344–2355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He L, Torres-Lockhart K, Forster N,
Ramakrishnan S, Greninger P, Garnett MJ, McDermott U, Rothenberg
SM, Benes CH and Ellisen LW: Mcl-1 and FBW7 control a dominant
survival pathway underlying HDAC and Bcl-2 inhibitor synergy in
squamous cell carcinoma. Cancer Discov. 3:324–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huelsemann MF, Patz M, Beckmann L,
Brinkmann K, Otto T, Fandrey J, Becker HJ, Theurich S, von
Bergwelt-Baildon M, Pallasch CP, et al: Hypoxia-induced p38 MAPK
activation reduces Mcl-1 expression and facilitates sensitivity
towards BH3 mimetics in chronic lymphocytic leukemia. Leukemia.
29:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Henson ES, Xiao W, Shome E, Azad
MB, Burton TR, Queau M, Sathya A, Eisenstat DD and Gibson SB: Bcl-2
family member Mcl-1 expression is reduced under hypoxia by the E3
ligase FBW7 contributing to BNIP3 induced cell death in glioma
cells. Cancer Biol Ther. 17:604–613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pitz MW, Lipson M, Hosseini B, Lambert P,
Guilbert K, Lister D, Schroeder G, Jones K, Mihalicioiu C and
Eisenstat DD: Extended adjuvant temozolomide with cis-retinoic acid
for adult glioblastoma. Curr Oncol. 19:3082012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhattacharyya S, Yu H, Mim C and
Matouschek A: Regulated protein turnover: Snapshots of the
proteasome in action. Nat Rev Mol Cell Biol. 15:122–133. 2014.
View Article : Google Scholar : PubMed/NCBI
|
